Tosi Roberto, Kilian Raphael, Rizzo Clara, Pagnacco Camilla, Marchini Giorgio
Ophthalmic Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37129, Verona, Italy.
Am J Ophthalmol Case Rep. 2022 Oct 4;28:101719. doi: 10.1016/j.ajoc.2022.101719. eCollection 2022 Dec.
To describe a case of bilateral pseudophakic malignant glaucoma treated with a new variant of irido-zonulo-hyaloid-vitrectomy.
A patient who developed refractory bilateral pseudophakic malignant glaucoma underwent an irido-zonulo-hyaloid-vitrectomy via the anterior chamber in both eyes, one 2-months apart from the other. The procedure involved the use of an 18 Gauge needle to perform a straight vertical irido-zonulo-hyaloidotomy and a 25 Gauge vitreous cutter to complete the vitrectomy. The intraocular pressure was recorded on day 1, day 7, day 14, then monthly until 6 months postoperatively, whereas an ultrasound biomicroscopy of the anterior chamber was performed on day 1 and 6 months after the operation. The malignant glaucoma resolved in both eyes with no intra- nor post-operative complications. At 6 months from the surgeries none of the eyes developed recurrences.
The new variant of irido-zonulo-hyaloid-vitrectomy we propose for the management of refractory pseudophakic malignant glaucoma resulted to be a safe and effective technique.
描述一例采用新型虹膜-悬韧带-玻璃体切除术治疗双侧人工晶状体性恶性青光眼的病例。
一名双侧人工晶状体性恶性青光眼难治性患者接受了双眼经前房的虹膜-悬韧带-玻璃体切除术,两眼手术间隔2个月。该手术使用18号针进行垂直直切口虹膜-悬韧带-玻璃体切开术,并使用25号玻璃体切割器完成玻璃体切除术。在术后第1天、第7天、第14天记录眼压,之后每月记录一次直至术后6个月,同时在术后第1天和6个月进行前房超声生物显微镜检查。双眼恶性青光眼均得到缓解,术中及术后均无并发症。术后6个月,双眼均未复发。
我们提出的用于治疗难治性人工晶状体性恶性青光眼的新型虹膜-悬韧带-玻璃体切除术是一种安全有效的技术。